FDAnews Drug Daily Bulletin

POZEN MAKES CHANGES TO ITS BOARD OF DIRECTORS

March 17, 2006
A A

Pozen Inc. has appointed Donald H. Namm and James J. Mauzey to its Board of Directors. Dr. Namm is a principal with BWA Consulting LLC. Most recently, Mr. Mauzey was president and chief executive officer of Bertek Pharmaceuticals, Inc. Berkek's focus was on dermatology, neurology and cardiology. In addition, Ted G. Wood and James R. Butler have elected to resign from the Board of Directors effective May 16, 2006, the date of the annual meeting of shareholders.

Carolina Newswire (http://carolinanewswire.com/news/News.cgi?database=topstories.db&command=viewone&id=4051&op=t)